|
|
The Biosimilars Conference will celebrate its 4th edition in Brussels. Participants will gain knowledge and share hands-on experiences with leading corporations in the pharma and biotech industry, through a series of presentations and interactive discussions. They will cover topics like the global regulatory environment, biobetters, current market trends, pricing and reimbursement strategies and biosimilars in emerging markets. They will also achieve new insight and share practical experiences with leading companies in the pharma and biotech industry.
Biosimilars Conference 2010 will allow:
Biosimilars Conference 2010 will allow:
- Assessing the global biosimilars market to assess its potential and profitability
- Summarizing the biosimilars status in emerging markets and how Europe can learn and benefit
- Evaluating the global legislative environment for biosimilars to understand the current market developments
- Identifing current and future trends to maximise the profitability of the biosimilars industry
- Discover successful pricing and reimbursement strategies in a biosimilar environment
- Learning about the potential of mAbs in the current situation of expiring patents
- Getting a critical analysis of the current market trends and developments to understand the impact of biosimilars on the healthcare industry.
Visitor Profile
The visitors for Biosimilars Conference 2010 include senior representatives from pharmaceutical companies and biotech working within the following areas:
- Research and Development
- Strategy
- Analytics
- Product Development
- Business Development
- Scientific Affairs
- Regulatory Affairs
- Medical Affairs
- Preclinical and Clinical Development
- Strategic Planning
- Business Strategy
- Corporate Development Strategy
Organizer
Arena International Events Group - VIBpharma
